Pulmonary arterial hypertension (PAH) is an increasingly understood disease, with the genetics and pathophysiology mapped out to the extent that new therapies are emerging.1 The epidemiology, however, ...
The FDA has just approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa).
FDA also approved the Ventana CLDN18 (43-14A) RxDx Assay, from Ventana Medical Systems, Inc. and Roche Diagnostics, to ...
((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...
The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...
Dr. Kurdi received his Medical Degree with honors from The Faculty of Medicine of Damascus University. Dr. Kurdi also completed his residency at St. Joseph Mercy Hospital, Oakland, MI, a fellowship in ...